Perigon Wealth Management LLC boosted its holdings in The Sherwin-Williams Company (NYSE:SHW - Free Report) by 443.1% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 8,032 shares of the specialty chemicals company's stock after purchasing an additional 6,553 shares during the quarter. Perigon Wealth Management LLC's holdings in Sherwin-Williams were worth $2,845,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also made changes to their positions in the business. Valued Wealth Advisors LLC raised its holdings in Sherwin-Williams by 88.9% in the 3rd quarter. Valued Wealth Advisors LLC now owns 68 shares of the specialty chemicals company's stock worth $26,000 after acquiring an additional 32 shares during the last quarter. First Personal Financial Services purchased a new position in shares of Sherwin-Williams in the third quarter worth $29,000. FSA Wealth Management LLC bought a new position in shares of Sherwin-Williams during the third quarter valued at $32,000. GHP Investment Advisors Inc. boosted its position in shares of Sherwin-Williams by 47.5% during the third quarter. GHP Investment Advisors Inc. now owns 87 shares of the specialty chemicals company's stock valued at $33,000 after buying an additional 28 shares during the last quarter. Finally, Capital Performance Advisors LLP purchased a new position in Sherwin-Williams in the 3rd quarter worth about $38,000. Institutional investors own 77.67% of the company's stock.
Sherwin-Williams Price Performance
NYSE SHW traded up $5.42 during trading on Thursday, hitting $365.83. 3,403,885 shares of the stock traded hands, compared to its average volume of 1,671,950. The company has a market capitalization of $92.13 billion, a P/E ratio of 36.44, a price-to-earnings-growth ratio of 2.78 and a beta of 1.22. The Sherwin-Williams Company has a 12-month low of $282.09 and a 12-month high of $400.42. The firm has a 50-day simple moving average of $360.59 and a 200-day simple moving average of $363.04. The company has a quick ratio of 0.51, a current ratio of 0.83 and a debt-to-equity ratio of 1.97.
Sherwin-Williams (NYSE:SHW - Get Free Report) last released its quarterly earnings data on Thursday, January 30th. The specialty chemicals company reported $2.09 EPS for the quarter, beating the consensus estimate of $2.07 by $0.02. Sherwin-Williams had a net margin of 11.09% and a return on equity of 74.45%. During the same quarter last year, the company earned $1.81 earnings per share. As a group, analysts predict that The Sherwin-Williams Company will post 11.32 EPS for the current year.
Insider Buying and Selling at Sherwin-Williams
In other news, SVP Gregory P. Sofish sold 2,565 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $378.63, for a total transaction of $971,185.95. Following the transaction, the senior vice president now owns 6,329 shares of the company's stock, valued at approximately $2,396,349.27. This represents a 28.84 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Mary L. Garceau sold 15,770 shares of the business's stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $397.92, for a total transaction of $6,275,198.40. Following the completion of the transaction, the senior vice president now directly owns 29,205 shares of the company's stock, valued at $11,621,253.60. This trade represents a 35.06 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.60% of the company's stock.
Analysts Set New Price Targets
A number of analysts have recently commented on the stock. KeyCorp reiterated a "sector weight" rating on shares of Sherwin-Williams in a research note on Monday, October 7th. Robert W. Baird boosted their target price on shares of Sherwin-Williams from $350.00 to $360.00 and gave the company a "neutral" rating in a research note on Wednesday, October 23rd. StockNews.com lowered Sherwin-Williams from a "buy" rating to a "hold" rating in a report on Thursday, November 28th. Wells Fargo & Company upped their price target on shares of Sherwin-Williams from $350.00 to $400.00 and gave the company an "equal weight" rating in a research report on Tuesday, October 15th. Finally, Royal Bank of Canada dropped their price objective on shares of Sherwin-Williams from $455.00 to $446.00 and set an "outperform" rating on the stock in a report on Thursday, October 24th. One analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Sherwin-Williams has a consensus rating of "Moderate Buy" and a consensus target price of $400.65.
Check Out Our Latest Stock Report on Sherwin-Williams
About Sherwin-Williams
(
Free Report)
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Further Reading
Before you consider Sherwin-Williams, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sherwin-Williams wasn't on the list.
While Sherwin-Williams currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.